U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07431762) titled 'Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Heart Valve Replacement' on Dec. 11, 2025.
Brief Summary: This trial is a multinational, multicenter, randomized, open-label, active-controlled clinical trial comparing the safety of aspirin versus vitamin K antagonists (warfarin) as oral antithrombotic therapy during the initial 6 months following tissue valve replacement (aortic or mitral).
Study Start Date: Feb. 01
Study Type: INTERVENTIONAL
Condition:
Valve Replacement Surgery
Intervention:
DRUG: Aspirin
100mg 1 tablet once daily for 6 months
DRUG: Vitamin ...